BFS
INDV icon

Bare Financial Services’s Indivior Pharmaceuticals INDV Stock Holding History

Bare Financial Services’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08K Buy
75
+29
+63% +$1.05K ﹤0.01% 1025
2026
Q1 		$1.4K Sell
46
-17
-27% -$561 ﹤0.01% 1109
2025
Q4 		$2.26K Sell
63
-3
-5% -$92 ﹤0.01% 822
2025
Q3 		$1.59K Buy
+66
New +$1.38K ﹤0.01% 875

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bare Financial Services's INDV Position: Q2 2026 in Review

Bare Financial Services increased its Indivior Pharmaceuticals (INDV) stake by 63% in Q2 2026, buying an estimated $1.05K and bringing the position to 75 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Bare Financial Services first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Bare Financial Services held 75 shares of Indivior Pharmaceuticals worth $3.08K as of Q2 2026.
  • Bare Financial Services bought 29 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.05K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1025 holding.
  • Bare Financial Services first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.